Your page scores 74 out of 100 for sameness against the 2 competitors you named.

Claims only you make, that buyers weigh, and that competitors can’t easily copy.

Territory you spend prominent space on that the set also occupies. Not every line is one to delete — the question is whether it has earned the space, or whether something only you can say should be there instead.

• Commodity · 100%Table stakesHero

  drives therapy starts and conversion

  • “Reduce friction across the prescription journey for patients and HCPs”
  • “Guides patients from first question through care, cost clarity, and enrollment”

  You say this 2 different ways.

  Ostro (Veeva) and Infinitus all cover this territory. Buyers may need to hear it, but in your hero it spends the first impression on shared ground.

  This is grouped wrong
  They say

  • Ostro (Veeva)“Give patients and HCPs a personalized pre-script journey powered by agentic AI”
  • Infinitus“More patients on therapy. Fewer barriers in the way.”
• Commodity · 100%Table stakesHero

  healthcare compliance and safety controls

  • “Hipaa Compliant”
  • “Ask questions and get trusted, med-legal-approved answers”

  You say this 2 different ways.

  Common ground with Ostro (Veeva) and Infinitus. Say it if buyers need it — lower on the page, where it is not the thing they read first.

  This is grouped wrong
  They say

  • Ostro (Veeva)“Ostro Sites for HCPs uses AI to frictionlessly provide MLR-approved content right to HCPs' fingertips”
  • Infinitus“When the system identifies a situation that requires a person, it routes immediately, before a response is given, not after”
• Commodity · 100%KeepHero

  purpose-built AI platform for pharma engagement

  • “The first AI healthcare navigator built for pharma”
  • “Replaces disconnected tools with a single engagement layer”

  You say this 2 different ways.

  Ostro (Veeva) and Infinitus all say what they are and who they are for, as every page in a category must. Keep it — it is orientation, not differentiation.

  This is grouped wrong
  They say

  • Ostro (Veeva)“AI-Powered Brand Engagement”
  • Infinitus“From prescription to adherence. Every step, coordinated.”
• Commodity · 100%Table stakesSection

  clinical and treatment support capabilities

  • “Find a nearby doctor or treatment center”
  • “Provide dosing guidelines and administration support”
  • “Get guidance on starting therapy”
  • “Receive refill support and ongoing adherence reminders”

  You say this 4 different ways.

  Ostro (Veeva) and Infinitus make the same claim. It cannot set you apart, so it should not carry the section.

  This is grouped wrong
  They say

  • Ostro (Veeva)“Ostro Consult uses an integrated telehealth platform to support the engagement journey by connecting patients to an experienced and qualified clinician”
  • Infinitus“Infinitus helps you keep patients on track through infusion cycles, refill windows, side effects, and the moments when life gets in the way”
• Commodity · 100%Table stakesSection

  increases patient and HCP engagement

  • “Drives engagement”

  A buyer comparing tabs sees this on Ostro (Veeva) and Infinitus. Yours earns nothing by repeating it up top; it can live lower down.

  This is grouped wrong
  They say

  • Ostro (Veeva)“Ostro Sites boosts patient engagement with an easy-to-implement, personalized 1:1 healthcare experience”
  • Infinitus“Reduce drop-off before and after purchase”
• Commodity · 100%Table stakesSection

  named customers and marquee logos as proof

  • “Trusted by leading pharmaceutical brands”

  Ostro (Veeva) and Infinitus got here first as far as a buyer can tell. Keep the fact for readers who need it; move the position to a claim only your page can make. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

  This is grouped wrong
  They say

  • Ostro (Veeva)“Trusted by 8 of top 10 biopharma companies across brand sites and email”
  • Infinitus“8 of the top 10 pharma organizations trust Infinitus to support their complete patient journey”
• Commodity · 100%Table stakesSection

  quantified performance results as proof

  • “Highest performing tactic on our website, engaging hundreds of new customers daily”

  Shared with Ostro (Veeva) and Infinitus. True of you, true of them — which is exactly why it will not decide anything. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

  This is grouped wrong
  They say

  • Ostro (Veeva)“264% Lift in specific high-value actions / Faster access to resources”
  • Infinitus“100% detection of potential adverse events”
• Contested · 50%SharpenHero

  available across multiple channels

  • “Available via Chat, Voice, and SMS”

  Ostro (Veeva) is on this territory too (50% of the set). It narrows the field without winning it — make it specific enough that it cannot be said of them. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

  This is grouped wrong
  They say

  • Ostro (Veeva)“Ostro Email powers AI-driven HCP engagement through email — enabling two-way, compliant conversations when it matters most”
• Contested · 50%SharpenHero

  guides patients through access and affordability

  • “Can help find cost savings for medications”
  • “Automate prior authorization calls to payors and pharmacies”
  • “Complete benefit verification and understand coverage”

  You say this 3 different ways.

  Infinitus is on this territory too (50% of the set). It narrows the field without winning it — make it specific enough that it cannot be said of them.

  This is grouped wrong
  They say

  • Infinitus“Connect patients to financial support programs that already exist for them – before cost barriers stop care”
• Contested · 50%SharpenSection

  delivers measurable ROI and lower cost

  • “Delivers ROI”

  Shared with Infinitus. Sharpen it to the thing only you do here, or it reads as a claim any of you could make. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

  This is grouped wrong
  They say

  • Infinitus“Up to 5x ROI on initial investment”
• Contested · 50%SharpenSection

  HCP-facing service and fulfilment workflows

  • “Connect HCPs to medical science liaisons and resources”
  • “Process sample requests and track delivery status”
  • “Capture prescriber information and route requests efficiently”

  You say this 3 different ways.

  Contested ground: Infinitus claim it as well. The version that wins names a mechanism, a number or a scope that theirs cannot match. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

  This is grouped wrong
  They say

  • Infinitus“Be available no matter when providers need answers”
• Contested · 50%SharpenSection

  reduces staff workload and support volume

  • “Reduce manual workload and accelerate time-to-therapy”
  • “Reduction in support inquiries”

  You say this 2 different ways.

  Across 2 of your lines: Shared with Infinitus. Sharpen it to the thing only you do here, or it reads as a claim any of you could make.

  This is grouped wrong
  They say

  • Infinitus“faster time to therapy”

Sameness measures how much your claims overlap with the sites compared. It does not measure message quality or whether buyers prefer you.

AI-analyzed: an AI read each page on its own and grouped the claims that say the same thing. No score here was written by a model — every number is computed from those groupings in our own code, with the weights below.

Trusted by